AI chatbots are being utilized as a potential solution to tackle mental health concerns among youths facing obstacles in accessing traditional therapy services. Using natural language processing and machine learning algorithms, these chatbots simulate conversations while offering mental health resources. However, their efficiency and potential risks are subjects of debate. FDA approval for treating mental health disorders is lacking, raising concerns about their ability to replace proven therapies for severe cases. Limited data exists on long-term effects and overall impact. Despite this, leading chatbot companies like Wysa and Woebot are gaining popularity, offering apps for various mental health needs, although none have been FDA approved. A recent review shows short-term reduction of depression symptoms, but experts emphasize that chatbots shouldn't replace traditional therapy or medical care for severe cases. Further research is needed to fully assess the effectiveness and risks of AI chatbots in addressing mental health needs.